FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

ANNIE UMBRICHT

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Intravenous Substance Abuse

Co-author Network

Publications

TOP 3
Kelly E Dunn; Jeffrey J Everly; Michael Fingerhood; Jeanniemarie Leoutsakos; Paul A Nuzzo; Will M Aklin; George E Bigelow; Anthony Louis DeFulio; Wendy D Donlin; ANNIE UMBRICHT; Kenneth Silverman
Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
Will M Aklin; George E Bigelow; Michael Fingerhood; Carl W. Lejuez; S Geoffrey Severtson; ANNIE UMBRICHT; Kenneth Silverman
Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
Porche K Henry; Bethea A Kleykamp; Eric C Strain; ANNIE UMBRICHT; Ryan Vandrey; George E Bigelow; Miriam Z Mintzer
Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of ANNIE UMBRICHT (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kelly E Dunn; Jeffrey J Everly; Michael Fingerhood; Jeanniemarie Leoutsakos; Paul A Nuzzo; Will M Aklin; George E Bigelow; Anthony Louis DeFulio; Wendy D Donlin; ANNIE UMBRICHT; Kenneth Silverman
Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
Experimental and clinical psychopharmacology 2013;21(1):74-83.
2012: Will M Aklin; George E Bigelow; Michael Fingerhood; Carl W. Lejuez; S Geoffrey Severtson; ANNIE UMBRICHT; Kenneth Silverman
Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
The Journal of clinical psychiatry 2012;73(8):e1056-61.
2012: Porche K Henry; Bethea A Kleykamp; Eric C Strain; ANNIE UMBRICHT; Ryan Vandrey; George E Bigelow; Miriam Z Mintzer
Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence.
Drug and alcohol dependence 2012;124(1-2):167-71.
2012: Anthony Louis DeFulio; ANNIE UMBRICHT; Jeffrey J Everly; Michael Fingerhood; George E Bigelow; Jeanniemarie Leoutsakos; Kenneth Silverman
Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial.
Drug and alcohol dependence 2012;120(1-3):48-54.
2011: Jeffrey J Everly; Anthony Louis DeFulio; Mikhail N Koffarnus; Jeanniemarie Leoutsakos; Wendy D Donlin; Will M Aklin; ANNIE UMBRICHT; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.
Addiction (Abingdon, England) 2011;106(7):1309-18.
2011: Ryan Vandrey; ANNIE UMBRICHT; Eric C Strain
Increased blood pressure after abrupt cessation of daily cannabis use.
Journal of addiction medicine 2011;5(1):16-20.
2010: Sharon L Walsh; Eric C Donny; Paul A Nuzzo; ANNIE UMBRICHT; George E Bigelow
Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory.
Drug and alcohol dependence 2010;106(1):28-37.
2009: David H Epstein; John Schmittner; ANNIE UMBRICHT; Jennifer R Schroeder; Eric T. Moolchan; Kenzie L. Preston
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
Drug and alcohol dependence 2009;101(1-2):92-100.
2008: Ryan K Lanier; ANNIE UMBRICHT; Joseph A Harrison; Elie S Nuwayser; George E Bigelow
Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.
Psychopharmacology 2008;198(2):149-58.
2007: Ryan K Lanier; ANNIE UMBRICHT; Joseph A Harrison; Elie S Nuwayser; George E Bigelow
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Addiction (Abingdon, England) 2007;102(10):1648-56.
2006: Jennifer R Schroeder; David H Epstein; ANNIE UMBRICHT; Kenzie L. Preston
Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.
Addictive behaviors 2006;31(5):868-79.
2005: Ivan Montoya; Jennifer R Schroeder; Kenzie L. Preston; LINO COVI; ANNIE UMBRICHT; Carlo Contoreggi; Paul J Fudala; Rolley E. Johnson; David A Gorelick
Influence of psychotherapy attendance on buprenorphine treatment outcome.
Journal of substance abuse treatment 2005;28(3):247-54.
2004: ANNIE UMBRICHT; Marilyn A Huestis; Edward J Cone; Kenzie L. Preston
Effects of high-dose intravenous buprenorphine in experienced opioid abusers.
Journal of clinical psychopharmacology 2004;24(5):479-87.
2004: Susan J Boyd; Neena F Thomas-Gosain; ANNIE UMBRICHT; Marvin J Tucker; JO LESLIE; Richard E Chaisson; Kenzie L. Preston
Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(3):281-91.
2004: Wallace B Pickworth; Eun M Lee; Mary E Abreu; ANNIE UMBRICHT; Kenzie L. Preston
A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users.
Pharmacology, biochemistry, and behavior 2004;77(4):711-5.
2004: Kenzie L. Preston; ANNIE UMBRICHT; Jennifer R Schroeder; M E Abreu; David H Epstein; Wallace B Pickworth
Cyclazocine: comparison to hydromorphone and interaction with cocaine.
Behavioural pharmacology 2004;15(2):91-102.
2004: Ivan Montoya; David A Gorelick; Kenzie L. Preston; Jennifer R Schroeder; ANNIE UMBRICHT; Lawrence J Cheskin; W Robert Lange; Carlo Contoreggi; Rolley E. Johnson; Paul J Fudala
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
Clinical pharmacology and therapeutics 2004;75(1):34-48.
2003: Jennifer R Schroeder; Anne E Gupman; David H Epstein; ANNIE UMBRICHT; Kenzie L. Preston
Do noncontingent vouchers increase drug use?
Experimental and clinical psychopharmacology 2003;11(3):195-201.
2003: ANNIE UMBRICHT; Donald R Hoover; Marvin J Tucker; JO LESLIE; Richard E Chaisson; Kenzie L. Preston
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Drug and alcohol dependence 2003;69(3):263-72.
2003: David H Epstein; Wesley E Hawkins; LINO COVI; ANNIE UMBRICHT; Kenzie L. Preston
Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 2003;17(1):73-82.
2003: Ronald I Herning; Warren Better; Kimberly Tate; ANNIE UMBRICHT; Kenzie L. Preston; Jean Lud Cadet
Methadone treatment induces attenuation of cerebrovascular deficits associated with the prolonged abuse of cocaine and heroin.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(3):562-8.
2002: Kenzie L. Preston; ANNIE UMBRICHT; David H Epstein
Abstinence reinforcement maintenance contingency and one-year follow-up.
Drug and alcohol dependence 2002;67(2):125-37.
2002: Van L King; Kenneth B Stoller; Michael Hayes; ANNIE UMBRICHT; Marian Currens; Michael Kidorf; James A Carter; Robert Schwartz; Robert K Brooner
A multicenter randomized evaluation of methadone medical maintenance.
Drug and alcohol dependence 2002;65(2):137-48.
2001: Kenzie L. Preston; ANNIE UMBRICHT; Conrad Jung Liang Wong; David H Epstein
Shaping cocaine abstinence by successive approximation.
Journal of consulting and clinical psychology 2001;69(4):643-54.
2001: Roy W Pickens; Kenzie L. Preston; Donna R Miles; Anne E Gupman; EO Johnson; David B Newlin; J Soriano; Marianne B M van den Bree; ANNIE UMBRICHT
Family history influence on drug abuse severity and treatment outcome.
Drug and alcohol dependence 2001;61(3):261-70.
2001: Eric T. Moolchan; ANNIE UMBRICHT; D Epstein
Therapeutic drug monitoring in methadone maintenance: choosing a matrix.
Journal of addictive diseases 2001;20(2):55-73.
2000: Marilyn A Huestis; Edward J Cone; Conrad Jung Liang Wong; ANNIE UMBRICHT; Kenzie L. Preston
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Journal of analytical toxicology 2000;24(7):509-21.
2000: Kenzie L. Preston; ANNIE UMBRICHT; David H Epstein
Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
Archives of general psychiatry 2000;57(4):395-404.
1999: ANNIE UMBRICHT; Ivan Montoya; Donald R Hoover; K L Demuth; C T Chiang; Kenzie L. Preston
Naltrexone shortened opioid detoxification with buprenorphine.
Drug and alcohol dependence 1999;56(3):181-90.
1999: Kenzie L. Preston; Marilyn A Huestis; Conrad Jung Liang Wong; ANNIE UMBRICHT; Bruce A Goldberger; Edward J Cone
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
Journal of analytical toxicology 1999;23(5):313-22.
1999: Kenzie L. Preston; Kenneth Silverman; ANNIE UMBRICHT; A DeJesus; Ivan Montoya; Charles R Schuster
Improvement in naltrexone treatment compliance with contingency management.
Drug and alcohol dependence 1999;54(2):127-35.
1995: Ivan Montoya; ANNIE UMBRICHT; Kenzie L. Preston
Buprenorphine for human immunovirus-positive opiate-dependent patients.
Biological psychiatry 1995;38(2):135-6.